Gene expression pattern in apoptotic QGY-7703 cells induced by homoharringtonine

Wei Jin1, Le-Feng Qu, Qin Chen

  • 1Breast Cancer Institute, Cancer Hospital, Department of Oncology, Shanghai Medical College, Institute of Biomedical Science, Fudan University, Shanghai 200032, China. zhimingshao@yahoo.com

Abstract

Insights

Homoharringtonine (HHT) induces apoptosis in liver cancer cells by altering gene expression. Key apoptosis signaling pathways were activated, indicating HHT

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Liver cancer remains a significant global health challenge.
  • Identifying novel therapeutic agents and understanding their mechanisms of action is crucial.
  • Homoharringtonine (HHT) has shown promise as an anti-cancer agent.

Purpose of the Study:

  • To identify genes involved in apoptosis induced by HHT in QGY-7703 liver cancer cells.
  • To elucidate the molecular mechanisms underlying HHT-induced cell death.

Main Methods:

  • Induction of apoptosis in QGY-7703 cells using HHT.
  • Assessment of apoptosis via DNA fragmentation and morphological changes.
  • Global gene expression profiling using cDNA microarray technology.
  • Validation of gene expression changes using Reverse Transcription Polymerase Chain Reaction (RT-PCR).

Main Results:

  • Significant alterations in the transcription levels of 78 individual mRNAs were observed.
  • 68% of affected genes were upregulated, and 32% were downregulated.
  • Affected genes included oncogenes, tumor suppressors, enzymes, and kinases, many related to apoptosis.

Conclusions:

  • HHT demonstrates potential as a therapeutic drug for liver cancer treatment.
  • Activation of TGF-beta, TNF, FAS, p38MAPK, and p53 signaling pathways was confirmed.
  • Inducible genes identified in this study warrant further investigation for their role in HHT-induced apoptosis.